RBC Capital cuts Brookfield Asset Management price target on valuation By Investing.com

RBC Capital cut Brookfield Asset Management’s price target to $65 from $74 but kept an Outperform rating, implying continued upside from the current $49.76 share price. The firm still expects BAM to raise about $150 billion in 2026, supported by private equity and infrastructure flagships, and noted $575 million in year-to-date buybacks plus a roughly 4% yield. Overall, the note is constructive on fundamentals and fundraising, though the lower target multiple signals some valuation caution.

Analysis

The more important signal is not the headline price target cut, but the implied normalization of Brookfield’s valuation gap versus Blackstone. If BAM can actually sustain fundraising near the cited run-rate while remaining materially less levered than U.S. peers, the market should start treating it less like a “growth at any price” compounder and more like a capital-light balance-sheet story with embedded optionality. That usually supports multiple stability even if headline AUM growth slows, because fee-bearing capital visibility becomes the dominant driver.

Second-order, this is a favorable setup for BX’s direct competitors in the listed alts complex: a re-rating toward peer-multiple discipline tends to compress dispersion across the group, which can help lower-variance platforms with credible fundraising engines. The flip side is that investors may be underestimating execution risk in converting fundraising into monetizable fee-bearing capital; if market volatility persists, the timing lag between announced capital raise and fee capture can stretch out, creating a short-term earnings/valuation mismatch.

The real catalyst stack is over the next 2-3 quarters: strong deployment and fundraising updates, continued buybacks, and any evidence that distributable earnings can outgrow the higher baseline of capital returns. The contrarian view is that the stock may already be discounting the “underlevered, undervalued, steady compounder” narrative, so upside likely requires either a broader multiple rerating for private markets or an acceleration in fee-related earnings per share, not just more fundraising headlines.

For risk, watch for a private-markets fundraising freeze, because that would hit BAM twice: lower near-term fee growth and a weaker narrative around capital efficiency. If that happens, the relative setup shifts toward BX, which has the stronger brand premium and may be better insulated from a valuation-compression regime.

Key Decisions for Investors

• Long BAM on weakness, 3-6 month horizon: use a pullback toward the low-$50s to build a position for multiple convergence toward peer levels; upside is driven by fundraising visibility and buybacks, downside is capped by existing yield and repurchases.
• Pair trade: long BAM / short BX for 2-4 months if you expect valuation dispersion to close through BAM rerating rather than peer de-rating; this works best if fundraising headlines remain strong but capital markets stay choppy.
• Buy BAM Jan-2027 calls or call spreads as a lower-carry expression of a 12-18 month multiple re-rating; structure around a move back toward the mid-$60s with limited premium at risk.
• Avoid chasing BX here unless you want the higher-quality premium; the risk/reward is less attractive than BAM if the market starts rewarding underlevered platforms with more room to re-rate.